SAV-IOL Seeks $20M in Financing for Active Intraocular Lens Concept with Real-Time Autofocus

April 13, 2018: By Jon Swedien

Swiss Advanced Vision (SAV-IOL) is looking to raise $20 million to bring an active intraocular lens with real-time autofocus to market in the next five to 10 years, the company announced April 10.

The Swiss company said it is developing the R-TASC (Real-Time Autofocus Servo Control), an active lens with real-time autofocus and wireless connectivity.

The purpose of R-TASC is to fully restore the accommodative function normally provided by the crystalline lens of the eye, SAV-IOL said.

The R-TASC lens is based on an energy capture system and will focus on any object viewed by the patient in real-time, the company said. SAV-IOL said the platform will also incorporate augmented reality and other interactive or connected features.

The R-TASC will be fitted alongside a monofocal lens (for distance vision) or added on patients who already have a monofocal lens but want to restore their visual accommodation, SAV-IOL said.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

Ivantis Gains US FDA Approval for Hydrus Microstent

US FDA Approves Sun Pharma’s CEQUA for Dry Eye

Regeneron Receives US FDA Approval for 12-Week Eylea Dosing

STAAR, Japan’s Shinjuku LASIK Clinic Sign Multiyear Agreement

Alcon Launches Finesse Sharkskin ILM Forceps

Imprimis’ Q2-2018 Revenues Increase 51 Percent to $10.4 Million

Bausch Health Revenues in Q2-2018 Drop 5 Percent

TearLab’s Q2-2018 Revenues Drop 8.5 Percent to $6.4 Million

DeepMind AI System Accurately Detects Eye Disease in OCT Scans at Moorfields

Study by MIT, Mass Eye and Ear Suggests Glaucoma is Autoimmune Disease

Study Indicates Insulin May Restore Vision in Glaucoma

CHOP Researchers Define Six ROP Indicators

Nicox Initiates Phase II Study of NCX 470 in Open-Angle Glaucoma, Ocular Hypertension

Eyenovia’s Microdose Latanoprost Delivers Drug with Precision, Lowers IOP in Proof-of-Concept Study

Rayner to Launch Sulcoflex Trifocal Toric IOL in September

CMS Allows Medicare Advantage Plans to Apply Step Therapy to Retinal Injections

Glaukos Reports Drug Collaboration with D. Western, Q2-2018 Net Sales Increase of 5 Percent

Allergan Will Co-develop Editas’ CRISPR Genome Editing Candidate for LCA10

Spark Reports Q2-2018 Net Sales of $4.3 Million for Luxturna

Aerie’s Rhopressa Posts $2.4 Million in Net Revenues in Q2-2018

Coming soon

2018 Ophthalmic Laser Report: A Global Market Analysis for 2017 to 2023 (Photocoagulation, Photodisruption, and SLT